Clinical Trial Update: Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating combining immunotherapy salvage surgery with intraoperative radiotherapy (IORT) for head and neck cancer, including carcinoma of unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary Head and Neck
• Head and Neck Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Oral Cavity
• Squamous Cell Carcinoma of the Pharynx

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Head and Neck Carcinoma of Unknown Primary, Locally Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | Status: RECRUITING